BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11756768)

  • 1. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.
    Lohmann CM; Coit DG; Brady MS; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Jan; 26(1):47-55. PubMed ID: 11756768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.
    Su LD; Fullen DR; Sondak VK; Johnson TM; Lowe L
    Cancer; 2003 Jan; 97(2):499-507. PubMed ID: 12518375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?
    Busam KJ; Pulitzer M
    Adv Anat Pathol; 2008 Sep; 15(5):253-62. PubMed ID: 18724099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
    Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
    Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spitz nevus and atypical spitzoid neoplasm.
    Miteva M; Lazova R
    Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.
    Gamblin TC; Edington H; Kirkwood JM; Rao UN
    Ann Surg Oncol; 2006 Dec; 13(12):1664-70. PubMed ID: 17024556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.
    Hung T; Piris A; Lobo A; Mihm MC; Sober AJ; Tsao H; Tanabe KK; Duncan LM
    Hum Pathol; 2013 Jan; 44(1):87-94. PubMed ID: 22939951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.
    Ghazi B; Carlson GW; Murray DR; Gow KW; Page A; Durham M; Kooby DA; Parker D; Rapkin L; Lawson DH; Delman KA
    Ann Surg Oncol; 2010 Sep; 17(9):2471-5. PubMed ID: 20224858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
    Ludgate MW; Fullen DR; Lee J; Lowe L; Bradford C; Geiger J; Schwartz J; Johnson TM
    Cancer; 2009 Feb; 115(3):631-41. PubMed ID: 19123453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review.
    Lallas A; Kyrgidis A; Ferrara G; Kittler H; Apalla Z; Castagnetti F; Longo C; Moscarella E; Piana S; Zalaudek I; Argenziano G
    Lancet Oncol; 2014 Apr; 15(4):e178-83. PubMed ID: 24694641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.
    Busam KJ; Murali R; Pulitzer M; McCarthy SW; Thompson JF; Shaw HM; Brady MS; Coit DG; Dusza S; Wilmott J; Kayton M; Laquaglia M; Scolyer RA
    Am J Surg Pathol; 2009 Sep; 33(9):1386-95. PubMed ID: 19609204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients with "atypical Spitz tumors." A report on 12 cases.
    Urso C; Borgognoni L; Saieva C; Ferrara G; Tinacci G; Begliomini B; Reali UM
    Hum Pathol; 2006 Jul; 37(7):816-23. PubMed ID: 16784980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spitzoid melanoma.
    Kamino H
    Clin Dermatol; 2009; 27(6):545-55. PubMed ID: 19880042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP).
    McArthur GJ; Banwell ME; Cook MG; Powell BW
    J Plast Reconstr Aesthet Surg; 2007; 60(8):952-4. PubMed ID: 17616368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.
    Scolyer RA; Murali R; McCarthy SW; Thompson JF
    Arch Pathol Lab Med; 2010 Dec; 134(12):1770-7. PubMed ID: 21128774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi with Spitz differentiation: diagnosis and management.
    Ahmadi N; Davison SP; Kauffman CL
    Laryngoscope; 2010 Dec; 120(12):2385-90. PubMed ID: 21072755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME immunohistochemistry of spitzoid neoplasms.
    Koh SS; Lau SK; Scapa JV; Cassarino DS
    J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
    Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
    Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dermal-based borderline melanocytic tumor: a categorical approach.
    Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
    J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.